Kyowa Kirin Co., Ltd. clinical trial pipeline

5 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 4 with minor changes only.

1. Notable

   KK8123 · X-linked Hypophosphatemia

   Primary completion pushed from Feb 11, 2028 to May 21, 2029

   Also in this update: Enrollment increased: 24 → 39 participants; Study completion pushed from May 10, 2028 to May 21, 2029

   Kyowa Kirin Co., Ltd.·Phase 1/2· NCT06525636· Registry history of NCT06525636 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.